跳至主要内容
临床试验/NCT02708446
NCT02708446Unknown4 期

A Randomized Controlled Trial to Compare Sublingual and Buccal Misoprostol Regimens After Mifepristone for Termination of Pregnancy 13 - 21 Weeks From Last Menstrual Period (LMP)

Gynuity Health Projects4 个研究点 分布在 4 个国家目标入组 320 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
320
试验地点
4
主要终点
Rate of successful abortion by 24 hours

研究概览

简要总结

The primary goal of this study is to directly compare repeat doses of sublingual and buccal routes of 400 mcg misoprostol following mifepristone for second trimester abortion in order to determine if sublingual route confers an advantage with respect to efficacy and median time to complete abortion.

详细描述

Eligible women 13-21 weeks gestation who give informed consent will be randomized to receive buccal or sublingual misoprostol. Participants will take 200mg mifepristone and return to the hospital 24 hours later to begin induction with misoprostol. 400mcg misoprostol will be given every 3 hours until the expulsion of the fetus and placenta.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Meet criteria to obtain abortion
  • Present with closed cervical os and no vaginal bleeding
  • Live fetus at time of presentation for service
  • Have no contraindications to study procedures, according to provider
  • Be able to consent to procedure, either by reading consent document or by having consent document read to her
  • Be willing to follow study procedures

排除标准

  • Known previous transmural uterine incision
  • Known allergy to mifepristone or misoprostol/prostaglandin or other contraindications to the use of mifepristone or misoprostol
  • Any contraindications to vaginal delivery
  • Presentation in active labor (defined as moderate to severe contractions every 10 minutes or less)

研究组 & 干预措施

Sublingual misoprostol

Active Comparator

200mg mifepristone + 400mcg sublingual misoprostol q3h

干预措施: Mifepristone (Drug)

Sublingual misoprostol

Active Comparator

200mg mifepristone + 400mcg sublingual misoprostol q3h

干预措施: Sublingual misoprostol (Drug)

Buccal misoprostol

Active Comparator

200mg mifepristone + 400mcg buccal misoprostol q3h

干预措施: Mifepristone (Drug)

Buccal misoprostol

Active Comparator

200mg mifepristone + 400mcg buccal misoprostol q3h

干预措施: Buccal misoprostol (Drug)

结局指标

主要结局

Rate of successful abortion by 24 hours

时间窗: 24 hours following the start of misoprostol

Defined as complete evacuation of uterus at 24 hours following start of misoprostol, using study drugs without recourse to any additional intervention.

Rate of successful abortion by 48 hours

时间窗: 48hours following the start of misoprostol

Defined as complete evacuation of uterus at 48 hours following start of misoprostol, using study drugs without recourse to any additional intervention.

次要结局

  • Median time from first dose of misoprostol to complete expulsion of complete expulsion (provider diagnosis of complete expulsion of fetus and placenta).(48 hours)
  • Pain scale (1-7) as reported by women on questionnaire(from first drug dose to complete expulsion as documented on study forms, up to 72 hours)
  • Percentage of patients requiring provision of additional interventions.(from first drug dose to complete expulsion as documented on study forms, up to 72 hours)
  • Total number of doses of misoprostol.(from first drug dose to complete expulsion as documented on study forms, up to 72 hours)
  • Women's acceptability of the assigned method based on 5 point acceptability scale in questionnaire(from first drug dose to complete expulsion as documented on study forms, up to 72 hours)
  • Rates of heavy bleeding, uterine rupture, or infection requiring additional treatment(1 month)

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

A Comparison of Sublingual and Buccal Misoprostol... | 临床试验